Results 201 to 210 of about 761,976 (296)
To model a nutrient‐restricted tumor microenvironment, breast cancer cells were adapted to low glucose and glutamine levels. In the adapted cells, BRD4‐driven enhancer activation increases pro‐invasive EDN1 expression, facilitated by ATF3/c‐JUN and reinforced by enhancer RNA.
Poshan Yugal Bhattarai +4 more
wiley +1 more source
Pharmacologic Profile of A<sub>2A</sub> Adenosine Receptors: Identifying Patients with Intermittent Claudication and Associated Myocardial Ischemia. [PDF]
Deharo P +11 more
europepmc +1 more source
Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation. [PDF]
Granade ME +8 more
europepmc +1 more source
CAR‐Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune‐Mediated Inflammation
CAR‐engineered cell therapies are expanding beyond cancer toward immune resetting, pathological‐cell clearance, matrix remodeling, and microenvironmental reprogramming in autoimmune, inflammatory, and fibrotic diseases. This Review compares CAR‐T, CAR‐macrophage, and CAR‐NK platforms and proposes controllable spatiotemporal reprogramming to align ...
Peng Jun Xu +6 more
wiley +1 more source
Current Understanding of the Role of Adenosine Receptors in Cancer. [PDF]
Venugopala KN, Buccioni M.
europepmc +1 more source
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update. [PDF]
IJzerman AP +4 more
europepmc +1 more source
This work designed an injectable metal‐drug supramolecular condensate formed from hafnium ions and alendronate (Hf‐ALN) and loaded with the COX‐2 inhibitor celecoxib (CXB) for synergistic radioimmunotherapy of postoperative osteosarcoma. Mechanistically, upon X‐ray irradiation, Hf enhances radiation energy deposition, ROS generation, and DNA damage ...
Tianhua Xiao +12 more
wiley +1 more source
The different effects of four adenosine receptors in liver fibrosis. [PDF]
Yang L +6 more
europepmc +1 more source
Machine‐learning‐driven transcriptomic analysis identifies FSTL3 as a key tumor‐microenvironment regulator in desmoplastic pancreatic adenocarcinoma. A cRGD‐modified liposome co‐loading gemcitabine and siFSTL3 serves as an irradiation‐triggered in situ nanovaccine. It synergizes with radiotherapy to induce ferroptosis and immunogenic cell death through
Chengyi Huang +11 more
wiley +1 more source

